PEGylation improves the hypoglycaemic efficacy of intranasally administered glucagon-like peptide-1 in type 2 diabetic db/db mice.
第一作者:
Y S,Youn
第一单位:
College of Pharmacy, Pusan National University, Busan, South Korea.
作者:
医学主题词
投药, 吸入(Administration, Inhalation);动物(Animals);血糖(Blood Glucose);糖尿病, 实验性(Diabetes Mellitus, Experimental);糖尿病, 2型(Diabetes Mellitus, Type 2);药物载体(Drug Carriers);胰高血糖素样肽1(Glucagon-Like Peptide 1);葡糖耐量试验(Glucose Tolerance Test);半衰期(Half-Life);降血糖药(Hypoglycemic Agents);胰岛素(Insulin);男(雄)性(Male);小鼠(Mice);小鼠, 近交C57BL(Mice, Inbred C57BL);小鼠, 突变型(Mice, Mutant Strains);聚乙烯二醇类(Polyethylene Glycols)
DOI
10.1111/j.1463-1326.2007.00823.x
PMID
18034839
发布时间
2018-12-01
- 浏览2
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



